Archives amgen

by in
Entry Author Date Location
Flexus Speeds From Inception to $1.25B Bristol Buyout In Less Than Two Years 02/23/15 San Francisco
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
West Coast Biotech Roundup: Tobira, Novartis, NantCell, & More 01/15/15 San Francisco
Second Exit for DeCode Investors as Spinout NextCODE Sold to WuXi 01/09/15 Boston
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
Patient Deaths Move Amgen To Pull Drug From Stomach Cancer Trials 11/24/14 Seattle
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Q&A: WA Gov. Inslee on Education, Life Sciences, Climate, R&D 10/24/14 Seattle
Cambia Grove Aims to Spur Healthcare Innovation in Seattle 10/24/14 Seattle
Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers 10/24/14 Wisconsin
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Page 2 of 15 « previous page · next page »